Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
Montalban-Bravo, Guillermo, Kanagal-Shamanna, Rashmi, Benton, Christopher B., Class, Caleb A., Chien, Kelly S., Sasaki, Koji, Naqvi, Kiran, Alvarado, Yesid, Kadia, Tapan M., Ravandi, Farhad, Daver, NaVolume:
4
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2019001101
Date:
February, 2020
File:
PDF, 1.61 MB
2020